Display Settings:

Format

Send to:

Choose Destination
    G Ital Med Lav Ergon. 2011 Apr-Jun;33(2):185-92.

    [Polychlorinated dibenzofurans and cancer].

    [Article in Italian]

    Source

    Dipartimento di Medicina Sperimentale e Applicata, Sezione di Medicina del Lavoro e Igiene Industriale, Università degli Studi di Brescia, Italy. apostoli@med.unibs.it

    Abstract

    The aim of the present report is to review the main scientific literature about polychlorinated dibenzofurans (PCDFs) and to focus the critical aspects of their identification and assessment of exposure. The 2,3,4,7,8- Pentachlorodibenzofuran (PeCDF) has been classified as carcinogenic to humans and included in Group 1 by IARC, as there is sufficient evidence of carcinogenicity in experimental animals and specific action mechanisms. Experimental studies demonstrated that PeCDF interacts through the binding with the aryl hydrocarbon receptor (AhR) as the 2,3,7,8-tetrachlorodibenzo-para dioxin (TCDD). The epidemiological studies on human exposure are limited to few cohort evaluations like the "Yusho" and "Yucheng" incidents, Swedish fishermen cohorts and workers employed in herbicide production. The PCDF as a group may be therefore classified at limited evidence of carcinogenicity. This paper concludes the cycle of review about other POPs, i.e. dioxins and PCBs.

    PMID:
    21796923
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk